Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
partnership
Biotech
BioAge secures Novartis deal worth up to $550M biobucks
The Novartis deal comes less than two weeks after BioAge discarded a phase 2 obesity trial and less than three months after its Nasdaq debut.
Gabrielle Masson
Dec 18, 2024 10:44am
Acepodia, Pfizer click together for chemistry-based cell therapy
Sep 3, 2024 5:00pm
JPM24: Flagship unveils life sci tech-focused initiative
Jan 9, 2024 12:58pm
WuXi CRDMO spinoff WuXi XDC partners with IntoCell
Jan 3, 2024 11:05am
48% of biotechs relying on Big Pharma for funding: ICON survey
Dec 18, 2023 9:00am
Beam offloads Verve rights to Lilly for up to $600M
Oct 31, 2023 6:00am
